AUTL (STOCKS)
Autolus Therapeutics plc American Depositary Share
$1.530000
-0.030000 (-1.92%)
Prev close: $1.560000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christian Martin Itin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $407.22M
- Employees
- 647
- P/E (TTM)
- -1.44
- P/B (TTM)
- 5.09
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.27 | $-0.26 | -0.0077 | -2.94% |
|
Dec 2025 (Q4)
|
$-0.34 | $-0.27 | -0.0684 | -25.18% |
|
Sep 2025 (Q3)
|
$-0.30 | $-0.23 | -0.0698 | -30.32% |
|
Jun 2025 (Q2)
|
$-0.18 | $-0.24 | +0.0604 | +25.12% |
Financial Statements
| Revenues | $92.62M |
| Benefits Costs and Expenses | $380.98M |
| Cost Of Revenue | $102.99M |
| Costs And Expenses | $380.98M |
| Gross Profit | -$10.36M |
| Nonoperating Income/Loss | -$23.54M |
| Operating Expenses | $254.46M |
| Selling, General, and Administrative Expenses | $142.29M |
| Research and Development | $112.17M |
| Operating Income/Loss | -$264.82M |
| Income/Loss From Continuing Operations After Tax | -$288.97M |
| Income/Loss From Continuing Operations Before Tax | -$288.36M |
| Income Tax Expense/Benefit | $609.00K |
| Interest Expense, Operating | $37.65M |
| Net Income/Loss | -$288.97M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$288.97M |
| Net Income/Loss Available To Common Stockholders, Basic | -$288.97M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.09 |
| Diluted Earnings Per Share | -$1.09 |
| Basic Average Shares | 798,427,973 |
| Diluted Average Shares | 798,427,973 |
| Assets | $527.07M |
| Current Assets | $368.84M |
| Inventory | $33.23M |
| Prepaid Expenses | $15.80M |
| Other Current Assets | $319.80M |
| Noncurrent Assets | $158.23M |
| Fixed Assets | $61.91M |
| Other Non-current Assets | $96.32M |
| Liabilities | $418.24M |
| Current Liabilities | $63.60M |
| Accounts Payable | $1.87M |
| Wages | $18.72M |
| Other Current Liabilities | $43.01M |
| Noncurrent Liabilities | $354.64M |
| Equity | $108.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $108.83M |
| Liabilities And Equity | $527.07M |
| Net Cash Flow From Operating Activities | -$273.32M |
| Net Cash Flow From Operating Activities, Continuing | -$273.32M |
| Net Cash Flow From Investing Activities | $314.16M |
| Net Cash Flow From Investing Activities, Continuing | $314.16M |
| Net Cash Flow From Financing Activities | -$137.96M |
| Net Cash Flow From Financing Activities, Continuing | -$141.51M |
| Exchange Gains/Losses | $732.00K |
| Net Cash Flow | -$92.83M |
| Net Cash Flow, Continuing | -$93.56M |
| Comprehensive Income/Loss | -$277.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$277.49M |
| Other Comprehensive Income/Loss | -$347.65M |
| Other Comprehensive Income/Loss Attributable To Parent | $11.48M |